Mark Perrin Lowrey (December 30, 1828 February 27, 1885) was a Southern Baptist preacher otherwise known as the "Preacher General". He is known for being ...
News
Invivo Therapeutics Holdings Corp Shoots up on Positive Six-Month Update of INSPIRE Study
CEO Mark Perrin commented: We are encouraged to see this patients significant neurological progress. The executive highlighted that the company plans to achieve full enrollment of the study by the end of 2016, which will allow the company to submit a Humanitarian Device Exemption (HDE) applicatio
Date: Mar 07, 2016
Category: Health
Source: Google
InVivo surges as spinal scaffold trial approaches endpoint
3rd conversion brings us one step closer to achieving the Objective Performance Criterion for the Inspire study. Our goal is to approach full enrollment of the pivotal Inspire study by the end of the year, which will allow for an HDE submission in 2017, CEO Mark Perrin said in a press release.